Published: May, 2018

The world market cancer biomarkers market is anticipated to flourish substantially within the forecast period that extends from the year 2017 to the year 2025. With various distinct segments of customer in the market propelling the demand for several types of products, it accounts for substantial scope of growth in the said market. In the years to come, the world market for cancer biomarkers is prognosticated to experience rise in competition. This is so owing to the fact that major players are taking up various strategies such as research and development activities, in a bid to sustain their position in the market. 

The international market for cancer biomarkers is highly fragmented. Currently, the said market has numerous market players. The report profiles a few of the eminent market players in the world market for cancer biomarkers, such as, Genomic Health, Thermo Fisher Scientific Inc., Agilent Technologies, bioMérieux SA, Abbott Laboratories, Novartis AG, F. Hoffmann-La Roche Ltd, Hologic, Inc., Illumina, Inc., Merck & Co., Inc.,.and QIAGEN.

In accordance with a recent market research report that has been published by Transparency Market Research, the world market for Cancer Biomarkers is forecasted to expand at a CAGR of 11.8% over the period between 2017 and 2025. The report also projects the international market for Cancer Biomarkers to reach a market valuation of around US$ 27.63 bn by the year 2025. The overall market was worth around US$ 10.25 bn in the year 2016. 

cancer biomarkers market

North America to Lead the Market over the Period of Forecast

The world market for cancer biomarkers has been regionally segmented into the geographies of South America, North America, Asia Pacific, Middle East and Africa, and Europe. The region of North America dominated the international market for cancer biomarkers in the year 2016 and is anticipated to remain dominant through the period of forecast. This is owing to high prevalence of various forms of cancer, rising health care expenditure resulting in the increase of demand for better health care services and diagnostic tests, and number of technological advancements in the field of cancer biomarkers. However, the market in Asia Pacific is expected to register substantial growth rate by the end of 2025 owing to availability of large base of patient pool and rising awareness about health. In addition to that, high percentage of geriatric population and increased disposable income are forecasted to propel the growth of the market.   

Increased Government Initiatives to Trigger Market Growth

Rise in the funding for cancer research by many different organizations is one of the important drivers filliping the demand in the world market for cancer biomarkers. Governments, particularly in many of the developed countries are investing in the activities of research and development pertaining to the treatment and cure of tumor. Due to such activities, the world market for cancer biomarkers is forecasted to attain speed in the years to come. Besides, measures are being taken by several governments so as to spread awareness with respect to cancer and it is also turning out to be beneficial for the rise in demand for cancer biomarkers.

The information shared that has been in this review is based on a TMR business report that contains the title, “Cancer Biomarkers Market (Test Type - PSA Tests, CTC Tests, AFP Tests, CA Tests, HER2 Tests, BRCA Tests, ALK Tests, CEA Tests, EGFR Mutation Tests, and KRAS Mutation Tests; Disease Indication - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Blood Cancer, Prostate Cancer, Ovarian Cancer, Stomach Cancer, and Liver Cancer) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017–2025”.

For the study the market has been segmented as follows:

Global Cancer Biomarkers Market Segmentation

  • By Test Type
    • PSA Tests
    • CTC Tests
    • AFP Tests
    • CA Tests
    • HER2 Tests
    • BRCA Tests
    • ALK Tests
    • CEA Tests
    • EGFR Mutation Tests
    • KRAS Mutation Tests
  • By Disease Indication
    • Breast Cancer
    • Lung Cancer,
    • Colorectal Cancer
    • Melanoma
    • Blood Cancer
    • Prostate Cancer
    • Ovarian Cancer
    • Stomach Cancer
    • Liver Cancer
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • Latin America

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com  
Website: https://www.transparencymarketresearch.com